Considering its heterogeneous biological nature, breast cancer can be clinically stratified into three main subtypes: luminal-like, human epidermal growth factor receptor 2 (HER2)-enriched, and triple-negative breast cancer (TNBC), according to the status of three critical receptors: estrogen receptor (ER), progestogen receptor (PR), and HER2 (2). Here, ESR1 is linked to breast carcinoma.